These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 9190877)
1. Functional activation of cerebral blood flow abolished by scopolamine is reversed by cognitive enhancers associated with cholinesterase inhibition: a positron emission tomography study in unanesthetized monkeys. Tsukada H; Kakiuchi T; Ando I; Ouchi Y J Pharmacol Exp Ther; 1997 Jun; 281(3):1408-14. PubMed ID: 9190877 [TBL] [Abstract][Full Text] [Related]
2. Age-related impairment of coupling mechanism between neuronal activation and functional cerebral blood flow response was restored by cholinesterase inhibition: PET study with microdialysis in the awake monkey brain. Tsukada H; Sato K; Kakiuchi T; Nishiyama S Brain Res; 2000 Feb; 857(1-2):158-64. PubMed ID: 10700563 [TBL] [Abstract][Full Text] [Related]
3. Regulation of cerebral blood flow response to somatosensory stimulation through the cholinergic system: a positron emission tomography study in unanesthetized monkeys. Tsukada H; Kakiuchi T; Ando I; Shizuno H; Nakanishi S; Ouchi Y Brain Res; 1997 Feb; 749(1):10-7. PubMed ID: 9070622 [TBL] [Abstract][Full Text] [Related]
4. Interactions of cholinergic and glutamatergic neuronal systems in the functional activation of cerebral blood flow response: a PET study in unanesthetized monkeys. Tsukada H; Kakiuchi T; Shizuno H; Nishiyama S Brain Res; 1998 Jun; 796(1-2):82-90. PubMed ID: 9689457 [TBL] [Abstract][Full Text] [Related]
5. FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, restores the regional cerebral blood flow response abolished by scopolamine but not by HA-966: a positron emission tomography study with unanesthetized rhesus monkeys. Tsukada H; Yamazaki S; Noda A; Inoue T; Matsuoka N; Kakiuchi T; Nishiyama S; Nishimura S Brain Res; 1999 Jun; 832(1-2):118-23. PubMed ID: 10375657 [TBL] [Abstract][Full Text] [Related]
6. [Pre-clinical evaluation of effects of acetylcholinesterase inhibition on the cerebral cholinergic neuronal system and cognitive function: PET study in conscious monkeys]. Tsukada H Nihon Yakurigaku Zasshi; 2004 Sep; 124(3):153-61. PubMed ID: 15333988 [TBL] [Abstract][Full Text] [Related]
7. Excitatory and inhibitory effects of second-generation cholinesterase inhibitors on rat gastrointestinal transit. Braida D; Virag W; Ottonello F; Sala M Pharmacol Res; 2000 Jun; 41(6):671-7. PubMed ID: 10816338 [TBL] [Abstract][Full Text] [Related]
8. Donepezil- and scopolamine-induced rCMRglu changes assessed by PET in conscious rhesus monkeys. Asai M; Fujikawa A; Noda A; Miyoshi S; Matsuoka N; Nishimura S Ann Nucl Med; 2009 Dec; 23(10):877-82. PubMed ID: 19924379 [TBL] [Abstract][Full Text] [Related]
9. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats. Wang H; Tang XC Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):27-30. PubMed ID: 10375753 [TBL] [Abstract][Full Text] [Related]
10. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors. Braida D; Paladini E; Griffini P; Lamperti M; Maggi A; Sala M Eur J Pharmacol; 1996 Apr; 302(1-3):13-20. PubMed ID: 8790986 [TBL] [Abstract][Full Text] [Related]
11. Physostigmine reversal of scopolamine-induced hypofrontality. Prohovnik I; Arnold SE; Smith G; Lucas LR J Cereb Blood Flow Metab; 1997 Feb; 17(2):220-8. PubMed ID: 9040502 [TBL] [Abstract][Full Text] [Related]
12. Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys. Rupniak NM; Tye SJ; Field MJ Psychopharmacology (Berl); 1997 Jun; 131(4):406-10. PubMed ID: 9226744 [TBL] [Abstract][Full Text] [Related]
13. Cholinergic enhancement improves performance on working memory by modulating the functional activity in distinct brain regions: a positron emission tomography regional cerebral blood flow study in healthy humans. Furey ML; Pietrini P; Alexander GE; Schapiro MB; Horwitz B Brain Res Bull; 2000 Feb; 51(3):213-8. PubMed ID: 10718513 [TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid (DHA) improves the age-related impairment of the coupling mechanism between neuronal activation and functional cerebral blood flow response: a PET study in conscious monkeys. Tsukada H; Kakiuchi T; Fukumoto D; Nishiyama S; Koga K Brain Res; 2000 Apr; 862(1-2):180-6. PubMed ID: 10799683 [TBL] [Abstract][Full Text] [Related]
15. Cholinergic modulation of cerebral cortical blood flow changes induced by trauma. Scremin OU; Li MG; Jenden DJ J Neurotrauma; 1997 Aug; 14(8):573-86. PubMed ID: 9300567 [TBL] [Abstract][Full Text] [Related]
16. Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow-metabolism ratio of normal rats. Scremin OU; Scremin AM; Heuser D; Hudgell R; Romero E; Imbimbo BP J Cereb Blood Flow Metab; 1993 Jul; 13(4):702-11. PubMed ID: 8314923 [TBL] [Abstract][Full Text] [Related]
17. Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models. Rupniak NM; Field MJ; Samson NA; Steventon MJ; Iversen SD Neurobiol Aging; 1990; 11(6):609-13. PubMed ID: 2280804 [TBL] [Abstract][Full Text] [Related]
18. The effects of scopolamine on changes in regional cerebral blood flow during classical conditioning of the human eyeblink response. Bahro M; Molchan SE; Sunderland T; Herscovitch P; Schreurs BG Neuropsychobiology; 1999 May; 39(4):187-95. PubMed ID: 10343183 [TBL] [Abstract][Full Text] [Related]
19. Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats. Shannon HE; Bemis KG; Hendrix JC; Ward JS J Pharmacol Exp Ther; 1990 Dec; 255(3):1071-7. PubMed ID: 2262893 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease. Shao D; Zou C; Luo C; Tang X; Li Y Bioorg Med Chem Lett; 2004 Sep; 14(18):4639-42. PubMed ID: 15324879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]